Skip to main content
. 2018 Jun 2;12:220–228. doi: 10.1016/j.omtn.2018.05.005

Figure 5.

Figure 5

CRISPR/Cas9-Mediated Therapy Improves the Compensatory Expression of Other Palmoplantar Keratins

(A) Immunoblotting against K2, K6, K14, and K16. (B) Semiquantitative immunoblotting analyses relative to GAPDH (mean ± SEM; n = 3; *p < 0.05; **p < 0.01). (C) IF staining for K1, K2, K5, K6, K10, K14, and K16. Each experiment was repeated at least three times. Scale bar, 50 μm.